# Study of Different Doses of a Novel Treatment for Onychomycosis

> **NCT00679965** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 159 (actual)

## Conditions studied

- Distal, Subungual Onychomycosis

## Interventions

- **DRUG:** AN2690, 2.5%
- **DRUG:** AN2690, 5%
- **DRUG:** AN2690, 7.5%
- **DRUG:** AN2690 Solution Vehicle

## Key facts

- **NCT ID:** NCT00679965
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02-28
- **Primary completion:** 2007-07-31
- **Final completion:** 2007-07-31
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2018-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679965, "Study of Different Doses of a Novel Treatment for Onychomycosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00679965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*